ALLOS THERAPEUTICS INC Operating Cash Flow
ALLOS THERAPEUTICS INC reported Operating Cash Flow of -$10.16 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-08-03
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$5.89M, a 119.72% decline year-over-year.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$4.27M.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$2.51M.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$9.06M.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2011 was -$752.00K.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2010 was -$63.66M.
- ALLOS THERAPEUTICS INC net cash provided by (used in) operating activities for fiscal 2009 was -$62.20M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | -$5.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$10.16M 10-Q · filed 2012-08-03 | -$12.68M derived: sum of 3 quarters · filed 2012-08-03 | -$21.74M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | -$4.27M 10-Q · filed 2012-05-03 | -$6.78M derived: sum of 2 quarters · filed 2012-05-03 | -$15.84M derived: sum of 3 quarters · filed 2012-05-03 | $14.05M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | -$2.51M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$11.57M derived: sum of 2 quarters · filed 2012-03-26 | $18.32M derived: sum of 3 quarters · filed 2012-08-03 | -$752.00K 10-K · filed 2012-03-26 |
| 2011-09-30 | -$9.06M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-03-26 | $20.83M derived: sum of 2 quarters · filed 2012-08-03 | $1.76M 10-Q/A · filed 2012-03-26 | -$8.98M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $29.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $10.82M 10-Q · filed 2012-08-03 | $81.00K derived: sum of 3 quarters · filed 2012-08-03 | -$13.20M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | -$19.07M 10-Q · filed 2012-05-03 | -$29.81M derived: sum of 2 quarters · filed 2012-05-03 | -$43.09M derived: sum of 3 quarters · filed 2012-05-03 | |
| 2010-12-31 | -$10.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-26 | -$24.02M derived: sum of 2 quarters · filed 2012-03-26 | -$63.66M 10-K · filed 2012-03-26 | |
| 2010-09-30 | -$13.28M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-26 | -$52.92M 10-Q/A · filed 2012-03-26 | ||
| 2010-06-30 | -$39.63M 10-Q/A · filed 2012-03-26 | |||
| 2009-12-31 | -$62.20M 10-K · filed 2012-03-26 |